NATCOPHARM Stock View

Natco Pharma Ltd

NATCOPHARM Stock View

(NSE)

Trade

₹ 859.95

-11.35 | -1.32

Market Cap ₹( Cr.)
154,025.50

Proj. P/E (x)
14.16

Proj. P/BV (x)
2.71

Proj. ROE (%)
20.53

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)
37,064.75

HOLD

Last Updated On.
17-Sep-2023

 

Copy Link

Natco Pharma Limited is an India-based vertically integrated, research and development (R&D)-focused pharmaceutical company. The Company is engaged in the business of pharmaceuticals, which comprises research and development, manufacturing and selling of bulk drugs and finished dosage formulations. The Company deals in the production of finished dosage formulations (FDF), which it sells in India, the United States and the Rest of the World, as well as active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic fusion technologies, production of high-potency APIs and peptides. The Company operates through two segments: pharmaceuticals and agrochemicals. The pharmaceuticals segment, the Company drives its sales through FDFs and APIs. The agrochemicals segment is focused on niche products, including pest management.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data